Diamond Necklace Possibly Linked to Marie Antoinette's Demise Up for Auctionhttps://english.aawsat.com/varieties/5079465-diamond-necklace-possibly-linked-marie-antoinettes-demise-auction
Diamond Necklace Possibly Linked to Marie Antoinette's Demise Up for Auction
An historic and highly important necklace set with nearly 500 diamonds weighing a total of approximately 300 carats and formally in the collection of the Marquess of Anglesey is pictured during an auction preview at Sotheby's and is estimated to fetch 1,600,000 to 2,000,000 CHF in Geneva, Switzerland, Nov 7, 2024. REUTERS/Denis Balibouse
Diamond Necklace Possibly Linked to Marie Antoinette's Demise Up for Auction
An historic and highly important necklace set with nearly 500 diamonds weighing a total of approximately 300 carats and formally in the collection of the Marquess of Anglesey is pictured during an auction preview at Sotheby's and is estimated to fetch 1,600,000 to 2,000,000 CHF in Geneva, Switzerland, Nov 7, 2024. REUTERS/Denis Balibouse
A diamond-studded necklace thought to be involved in a scandal that led to the eventual downfall of the last queen of France, Marie Antoinette, is being sold in Geneva next week.
The Georgian-era piece containing 300 carats of diamonds being sold by a Asian private collector in Geneva on Nov. 13 is valued at around 2 million Swiss francs ($2.29 million), Sotheby's said, although it may fetch much more.
The piece was at the center of a scandal in the 1780s known as the 'Diamond Necklace Affair' in which a hard-up noblewoman named Jeanne de la Motte pretended to be the French queen and acquired the necklace in her name without payment
A subsequent trial found the queen blameless, yet did little to alleviate her growing notoriety for extravagance which helped fuel the French Revolution and Marie Antoinette's beheading.
"It's likely or possible that some of these diamonds may have come from the famous diamond necklace that led to the downfall of Marie Antoinette," Jessica Wyndham, head of magnificent jewels sales for Sotheby's, told Reuters on Thursday.
"What we've seen is that jewelry with a noble provenance can generate a huge amount of excitement," she added, citing a pearl pendant belonging to the French queen which the auction house sold in 2018 for many times its initial estimate.
The diamonds of the original piece, crafted in 1776, were later sold piecemeal on the black market so are almost impossible to trace. However, some experts say the quality and age of the diamonds point to a match.
The necklace, which resembles a neck scarf, can be worn open or knotted at the front. One of its previous owners was Britain's Marquess of Anglesey and a family member wore it on the occasion of Queen Elizabeth II's coronation, according to Sotheby's.
"I think it's one of the most exciting pieces that we've had for a long time, not only with the provenance, but the design," said Wyndham.
5 Things We Know and Still Don’t Know about COVID, 5 Years after It Appearedhttps://english.aawsat.com/varieties/5097458-5-things-we-know-and-still-don%E2%80%99t-know-about-covid-5-years-after-it-appeared
A medical worker takes a swab sample from a worker of the China Star Optoelectronics Technology (CSOT) company during a round of COVID-19 tests in Wuhan in central China's Hubei province, Aug. 5, 2021. (Chinatopix via AP, File)
TT
TT
5 Things We Know and Still Don’t Know about COVID, 5 Years after It Appeared
A medical worker takes a swab sample from a worker of the China Star Optoelectronics Technology (CSOT) company during a round of COVID-19 tests in Wuhan in central China's Hubei province, Aug. 5, 2021. (Chinatopix via AP, File)
Five years ago, a cluster of people in Wuhan, China, fell sick with a virus never before seen in the world.
The germ didn't have a name, nor did the illness it would cause. It wound up setting off a pandemic that exposed deep inequities in the global health system and reshaped public opinion about how to control deadly emerging viruses.
The virus is still with us, though humanity has built up immunity through vaccinations and infections. It's less deadly than it was in the pandemic's early days and it no longer tops the list of leading causes of death. But the virus is evolving, meaning scientists must track it closely.
Where did the SARS-CoV-2 virus come from? We don’t know. Scientists think the most likely scenario is that it circulated in bats, like many coronaviruses. They think it then infected another species, probably racoon dogs, civet cats or bamboo rats, which in turn infected humans handling or butchering those animals at a market in Wuhan, where the first human cases appeared in late November 2019.
That's a known pathway for disease transmission and likely triggered the first epidemic of a similar virus, known as SARS. But this theory has not been proven for the virus that causes COVID-19. Wuhan is home to several research labs involved in collecting and studying coronaviruses, fueling debate over whether the virus instead may have leaked from one.
It's a difficult scientific puzzle to crack in the best of circumstances. The effort has been made even more challenging by political sniping around the virus' origins and by what international researchers say are moves by China to withhold evidence that could help.
The true origin of the pandemic may not be known for many years — if ever.
People attend an exhibition on the city's fight against the coronavirus in Wuhan in central China's Hubei province, Jan. 23, 2021. (AP)
How many people died from COVID-19? Probably more than 20 million. The World Health Organization has said member countries reported more than 7 million deaths from COVID-19, but the true death toll is estimated to be at least three times higher.
In the US, an average of about 900 people a week have died of COVID-19 over the past year, according to the US Centers for Disease Control and Prevention.
The coronavirus continues to affect older adults the most. Last winter in the US, people aged 75 and older accounted for about half the nation’s COVID-19 hospitalizations and in-hospital deaths, according to the CDC.
"We cannot talk about COVID in the past, since it’s still with us," WHO director Tedros Adhanom Ghebreyesus said.
What vaccines were made available? Scientists and vaccine-makers broke speed records developing COVID-19 vaccines that have saved tens of millions of lives worldwide – and were the critical step to getting life back to normal.
Less than a year after China identified the virus, health authorities in the US and Britain cleared vaccines made by Pfizer and Moderna. Years of earlier research — including Nobel-winning discoveries that were key to making the new technology work — gave a head start for so-called mRNA vaccines.
Today, there’s also a more traditional vaccine made by Novavax, and some countries have tried additional options. Rollout to poorer countries was slow but the WHO estimates more than 13 billion doses of COVID-19 vaccines have been administered globally since 2021.
The vaccines aren't perfect. They do a good job of preventing severe disease, hospitalization and death, and have proven very safe, with only rare serious side effects. But protection against milder infection begins to wane after a few months.
Like flu vaccines, COVID-19 shots must be updated regularly to match the ever-evolving virus — contributing to public frustration at the need for repeated vaccinations. Efforts to develop next-generation vaccines are underway, such as nasal vaccines that researchers hope might do a better job of blocking infection.
This undated electron microscope image made available by the US National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow, emerging from the surface of cells, pink, cultured in the lab. (NIAID-RML via AP, File)
Which variant is dominating now? Genetic changes called mutations happen as viruses make copies of themselves. And this virus has proven to be no different.
Scientists named these variants after Greek letters: alpha, beta, gamma, delta and omicron. Delta, which became dominant in the US in June 2021, raised a lot of concerns because it was twice as likely to lead to hospitalization as the first version of the virus.
Then in late November 2021, a new variant came on the scene: omicron.
"It spread very rapidly," dominating within weeks, said Dr. Wesley Long, a pathologist at Houston Methodist in Texas. "It drove a huge spike in cases compared to anything we had seen previously."
But on average, the WHO said, it caused less severe disease than delta. Scientists believe that may be partly because immunity had been building due to vaccination and infections.
"Ever since then, we just sort of keep seeing these different subvariants of omicron accumulating more different mutations," Long said. "Right now, everything seems to locked on this omicron branch of the tree."
The omicron relative now dominant in the US is called XEC, which accounted for 45% of variants circulating nationally in the two-week period ending Dec. 21, the CDC said. Existing COVID-19 medications and the latest vaccine booster should be effective against it, Long said, since "it’s really sort of a remixing of variants already circulating."
Employees disinfect streets and shops inside Istanbul's famous Grand Bazaar to prevent the spread of coronavirus. (EPA)
What do we know about long COVID? Millions of people remain in limbo with a sometimes disabling, often invisible, legacy of the pandemic called long COVID.
It can take several weeks to bounce back after a bout of COVID-19, but some people develop more persistent problems. The symptoms that last at least three months, sometimes for years, include fatigue, cognitive trouble known as "brain fog," pain and cardiovascular problems, among others.
Doctors don’t know why only some people get long COVID. It can happen even after a mild case and at any age, although rates have declined since the pandemic's early years. Studies show vaccination can lower the risk.
It also isn't clear what causes long COVID, which complicates the search for treatments. One important clue: Increasingly researchers are discovering that remnants of the coronavirus can persist in some patients’ bodies long after their initial infection, although that can’t explain all cases.
